Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Determinants of performance of supplemental immunization activities for polio eradication in Uttar Pradesh, India: social mobilization activities of the Social mobilization Network (SM Net) and Core Group Polio Project (CGPP)

Authors: William M Weiss, Md Hafizur Rahman, Roma Solomon, Dora Ward

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

The primary strategy to interrupt transmission of wild poliovirus in India is to improve supplemental immunization activities (SIAs) and routine immunization coverage in priority districts. The CORE Group, part of the Social Mobilization Network (SM Net), has been successful in improving SIA coverage in high-risk areas of Uttar Pradesh (UP). The SM Net works through community level mobilisers (from the CORE Group and UNICEF) and covers more than 2 million children under the age of five. In this paper, we examine the reasons the CORE Group had been successful through exploration of which social mobilization activities of the CORE Group predicted better performance of SIAs.

Methods

We carried out a secondary data analysis of routine monitoring information collected by the CORE Group and the Government of India for SIAs. These data included information about vaccination outcomes of SIAs in CORE Group areas and non-CORE Group areas within the districts where the CORE Group operates, along with information about the number of various social mobilization activities carried out for each SIA. We employed Generalized Linear Latent and Mixed Model (GLLAMM) statistical analysis methods to identify which social mobilization activities predicted SIA performance, and to account for the intra-class correlation (ICC) between multiple observations within the same geographic areas over time.

Results

The number of mosque announcements carried out was the most consistent determinant of improved SIA performance across various performance measures. The number of Bullawa Tollies carried out also appeared to be an important determinant of improved SIA performance. The number of times other social mobilization activities were carried out did not appear to determine better SIA performance.

Conclusions

Social mobilization activities can improve the performance of mass vaccination campaigns. In the CORE Group areas, the number of mosque announcements and Bullawa Tollies carried out were important determinants of desired SIA outcomes. The CORE Group and SM Net should conduct sufficient numbers of these activities in support of each SIA. It is likely, however, that the quality of social mobilization activities (not studied here) is as or more important than the quantity of activities; quality measures of social mobilization activities should be investigated in the future as to how they determine vaccination performance.
Literature
1.
go back to reference Centers for Disease C, Prevention: Progress toward interruption of wild poliovirus transmission - worldwide, 2009. MMWRMorbidity and mortality weekly report. 2010, 59 (18): 545-550. Centers for Disease C, Prevention: Progress toward interruption of wild poliovirus transmission - worldwide, 2009. MMWRMorbidity and mortality weekly report. 2010, 59 (18): 545-550.
2.
go back to reference WHO: Performance of acute flaccid paralysis (AFP) surveillance and incidence of poliomyelitis, 2011. Wkly Epidemiol Rec. 2011, 86 (26): 271-275. WHO: Performance of acute flaccid paralysis (AFP) surveillance and incidence of poliomyelitis, 2011. Wkly Epidemiol Rec. 2011, 86 (26): 271-275.
3.
go back to reference WHO: Performance of acute flaccid paralysis (AFP) surveillance and incidence of poliomyelitis, 2010. Wkly Epidemiol Rec. 2010, 85 (50): 503-507. WHO: Performance of acute flaccid paralysis (AFP) surveillance and incidence of poliomyelitis, 2010. Wkly Epidemiol Rec. 2010, 85 (50): 503-507.
4.
go back to reference WHO: Progress towards eradicating poliomyelitis in India, January 2009 - October 2010. Wkly Epidemiol Rec. 2010, 85 (50): 497-503. WHO: Progress towards eradicating poliomyelitis in India, January 2009 - October 2010. Wkly Epidemiol Rec. 2010, 85 (50): 497-503.
6.
go back to reference WHO: Global polio eradication initiative strategic plan 2010–2012. 2010, WHO (World Health Organization), Geneva WHO: Global polio eradication initiative strategic plan 2010–2012. 2010, WHO (World Health Organization), Geneva
7.
go back to reference Weiss WM, Rahman MH, Solomon R, Singh V, Ward D: Outcomes of polio eradication activities in Uttar Pradesh, India: the Social Mobilization Network (SM Net) and Core Group Polio Project (CGPP). BMC Infect Dis. 2011, 11: 117-10.1186/1471-2334-11-117.CrossRefPubMedPubMedCentral Weiss WM, Rahman MH, Solomon R, Singh V, Ward D: Outcomes of polio eradication activities in Uttar Pradesh, India: the Social Mobilization Network (SM Net) and Core Group Polio Project (CGPP). BMC Infect Dis. 2011, 11: 117-10.1186/1471-2334-11-117.CrossRefPubMedPubMedCentral
8.
go back to reference Weiss WM, Winch PJ, Burnham G: Factors associated with missed vaccination during mass immunization campaigns. J Heal Popul Nutr. 2009, 27 (3): 358-367. Weiss WM, Winch PJ, Burnham G: Factors associated with missed vaccination during mass immunization campaigns. J Heal Popul Nutr. 2009, 27 (3): 358-367.
9.
go back to reference Vashishtha VM, Kalra A, John TJ, Thacker N, Agarwal RK, Polio Eradication C Indian Academy of P: Recommendations of 2nd National Consultative Meeting of Indian Academy of Pediatrics (IAP) on polio eradication and improvement of routine immunization. Indian Pediatr. 2008, 45 (5): 367-378.PubMed Vashishtha VM, Kalra A, John TJ, Thacker N, Agarwal RK, Polio Eradication C Indian Academy of P: Recommendations of 2nd National Consultative Meeting of Indian Academy of Pediatrics (IAP) on polio eradication and improvement of routine immunization. Indian Pediatr. 2008, 45 (5): 367-378.PubMed
10.
go back to reference Arora NK, Chaturvedi S, Dasgupta R: Global lessons from India’s poliomyelitis elimination campaign. Bulletin of the World Health Organization. 2010, 88 (3): 232-234. 10.2471/BLT.09.072058.CrossRefPubMedPubMedCentral Arora NK, Chaturvedi S, Dasgupta R: Global lessons from India’s poliomyelitis elimination campaign. Bulletin of the World Health Organization. 2010, 88 (3): 232-234. 10.2471/BLT.09.072058.CrossRefPubMedPubMedCentral
12.
go back to reference Heck RH, Thomas SL: An introduction to multilevel modeling techniques. 2000, Lawrence Erlbaum Associates, Mahwah, NJ Heck RH, Thomas SL: An introduction to multilevel modeling techniques. 2000, Lawrence Erlbaum Associates, Mahwah, NJ
13.
go back to reference Goldstein H: Multilevel statistical models. 1995, Edward Arnold, London Goldstein H: Multilevel statistical models. 1995, Edward Arnold, London
14.
go back to reference StataCorp: STATA statistical software 12.0. 2011, College Station, TX StataCorp: STATA statistical software 12.0. 2011, College Station, TX
Metadata
Title
Determinants of performance of supplemental immunization activities for polio eradication in Uttar Pradesh, India: social mobilization activities of the Social mobilization Network (SM Net) and Core Group Polio Project (CGPP)
Authors
William M Weiss
Md Hafizur Rahman
Roma Solomon
Dora Ward
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-17

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine